Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-068456

Chief Executive Officer gave up 37,818 shares (to pay taxes)

  • Chief Executive Officer acquired 80,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2021-12-03 Option exercise +80,000 299,153 D: show line 1 in the form
Kulkarni Samarth Chief Executive Officer 2021-12-06 Shares withheld for taxes −37,818 $69.17 $2,615,871 261,335 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2021-12-03 Option exercise · Restricted Stock Units +80,000 40,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…